CHG Stock Overview
Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand.
Chularat Hospital Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||฿3.88|
|52 Week High||฿4.16|
|52 Week Low||฿3.08|
|1 Month Change||4.87%|
|3 Month Change||3.74%|
|1 Year Change||-3.00%|
|3 Year Change||68.70%|
|5 Year Change||68.70%|
|Change since IPO||345.98%|
Recent News & Updates
|CHG||TH Healthcare||TH Market|
Return vs Industry: CHG underperformed the TH Healthcare industry which returned 25.1% over the past year.
Return vs Market: CHG underperformed the TH Market which returned 8% over the past year.
|CHG Average Weekly Movement||3.0%|
|Healthcare Industry Average Movement||4.3%|
|Market Average Movement||4.7%|
|10% most volatile stocks in TH Market||10.4%|
|10% least volatile stocks in TH Market||2.3%|
Stable Share Price: CHG is less volatile than 75% of TH stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: CHG's weekly volatility (3%) has been stable over the past year.
About the Company
Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand. It operates through two segments, Hospital Operations and Other Businesses. The company also distributes medical instruments and dietary supplement products.
Chularat Hospital Fundamentals Summary
|CHG fundamental statistics|
Is CHG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CHG income statement (TTM)|
|Cost of Revenue||฿6.59b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.48|
|Net Profit Margin||37.48%|
How did CHG perform over the long term?See historical performance and comparison
5.2%Current Dividend Yield
Does CHG pay a reliable dividends?See CHG dividend history and benchmarks
|Chularat Hospital dividend dates|
|Ex Dividend Date||Aug 24 2022|
|Dividend Pay Date||Sep 09 2022|
|Days until Ex dividend||10 days|
|Days until Dividend pay date||26 days|
Does CHG pay a reliable dividends?See CHG dividend history and benchmarks
Is CHG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CHG?
Other financial metrics that can be useful for relative valuation.
|What is CHG's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does CHG's PE Ratio compare to its peers?
|CHG PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
BCH Bangkok Chain Hospital
PRINC Principal Capital
RAM Ramkhamhaeng Hospital
THG Thonburi Healthcare Group
CHG-R Chularat Hospital
Price-To-Earnings vs Peers: CHG is good value based on its Price-To-Earnings Ratio (8x) compared to the peer average (21.9x).
Price to Earnings Ratio vs Industry
How does CHG's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: CHG is good value based on its Price-To-Earnings Ratio (8x) compared to the TH Healthcare industry average (14.8x)
Price to Earnings Ratio vs Fair Ratio
What is CHG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||8x|
|Fair PE Ratio||14.8x|
Price-To-Earnings vs Fair Ratio: CHG is good value based on its Price-To-Earnings Ratio (8x) compared to the estimated Fair Price-To-Earnings Ratio (14.8x).
Share Price vs Fair Value
What is the Fair Price of CHG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CHG (THB3.88) is trading above our estimate of fair value (THB2.47)
Significantly Below Fair Value: CHG is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Chularat Hospital forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CHG's earnings are forecast to decline over the next 3 years (-28.7% per year).
Earnings vs Market: CHG's earnings are forecast to decline over the next 3 years (-28.7% per year).
High Growth Earnings: CHG's earnings are forecast to decline over the next 3 years.
Revenue vs Market: CHG's revenue is expected to decline over the next 3 years (-11.7% per year).
High Growth Revenue: CHG's revenue is forecast to decline over the next 3 years (-11.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CHG's Return on Equity is forecast to be low in 3 years time (18.3%).
Discover growth companies
How has Chularat Hospital performed over the past 5 years?
Past Performance Score6/6
Past Performance Score 6/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CHG has high quality earnings.
Growing Profit Margin: CHG's current net profit margins (37.5%) are higher than last year (16.8%).
Past Earnings Growth Analysis
Earnings Trend: CHG's earnings have grown significantly by 46.6% per year over the past 5 years.
Accelerating Growth: CHG's earnings growth over the past year (463.6%) exceeds its 5-year average (46.6% per year).
Earnings vs Industry: CHG earnings growth over the past year (463.6%) exceeded the Healthcare industry 231.4%.
Return on Equity
High ROE: CHG's Return on Equity (58.6%) is considered outstanding.
Discover strong past performing companies
How is Chularat Hospital's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CHG's short term assets (THB7.6B) exceed its short term liabilities (THB2.6B).
Long Term Liabilities: CHG's short term assets (THB7.6B) exceed its long term liabilities (THB506.8M).
Debt to Equity History and Analysis
Debt Level: CHG has more cash than its total debt.
Reducing Debt: CHG's debt to equity ratio has reduced from 20.1% to 4.1% over the past 5 years.
Debt Coverage: CHG's debt is well covered by operating cash flow (1310.1%).
Interest Coverage: CHG's interest payments on its debt are well covered by EBIT (405.2x coverage).
Discover healthy companies
What is Chularat Hospital current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Cash Flow Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CHG's dividend (5.15%) is higher than the bottom 25% of dividend payers in the TH market (1.69%).
High Dividend: CHG's dividend (5.15%) is low compared to the top 25% of dividend payers in the TH market (5.46%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, CHG has been paying a dividend for less than 10 years.
Growing Dividend: CHG's dividend payments have increased, but the company has only paid a dividend for 9 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (41.4%), CHG's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (50%), CHG's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Kumpol Plussind (69 yo)
Dr. Kumphol Plussind, M.D. has been Chief Executive Officer, Managing Director and Executive Director at Chularat Hospital Public Company Limited since 2004. Dr. Plussind has been a Director of Thai Amdon...
Experienced Management: CHG's management team is seasoned and experienced (9.8 years average tenure).
Experienced Board: CHG's board of directors are seasoned and experienced ( 18.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Chularat Hospital Public Company Limited's employee growth, exchange listings and data sources
- Name: Chularat Hospital Public Company Limited
- Ticker: CHG
- Exchange: SET
- Founded: 1986
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: ฿42.680b
- Shares outstanding: 11.00b
- Website: https://www.chularat.com
- Chularat Hospital Public Company Limited
- 88/8-9, Teparak Km. 15 Road
- Tambol Bangpla
- Samut Prakan
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/13 00:00|
|End of Day Share Price||2022/08/11 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.